In addition, it has been demonstrated that the metabolic reprogramming towards de novo serine/glycine biosynthesis due to ILF3 overexpression in CRC promotes tumor growth in vivo and the formation of patient-derived organoids (PDO) and patient-derived xenografts (PDX) [49]. Here, ILF3 is linked to colorectal carcinoma.